Cranberry products in the prevention of recurrent urinary tract infections in adult women: Efficacy, safety, and place in non-antibiotic prophylaxis - literature review.

Q4 Medicine
Julia Gładkowska, Marta Tokaj, Katarzyna Mórdas-Żylińska
{"title":"Cranberry products in the prevention of recurrent urinary tract infections in adult women: Efficacy, safety, and place in non-antibiotic prophylaxis - literature review.","authors":"Julia Gładkowska, Marta Tokaj, Katarzyna Mórdas-Żylińska","doi":"10.36740/WLek/222496","DOIUrl":null,"url":null,"abstract":"<p><p>Recurrent urinary tract infections are among the most frequent bacterial infections in adult women and are associated with impaired quality of life, like repeated medical consultations, and cumulative exposure to antibiotics. In the context of increasing antimicrobial resistance, non-antibiotic preventive strategies have attracted growing attention. Cranberry products remain one of the most commonly used and most extensively studied options. The aim of this review was to summarize current evidence regarding the efficacy, safety, and practical role of cranberry products in the prevention of recurrent urinary tract infections in adult women. Contemporary guidelines, systematic reviews, meta-analyses, and randomized clinical trials indicate that cranberry products may reduce recurrence risk, particularly in women with recurrent uncomplicated cystitis. However, cranberry should not be regarded as a single uniform intervention. The clinical effect appears to depend on formulation, proanthocyanidin content, and duration of administration. Preparations providing at least 36 mg of proanthocyanidins daily seem to offer the most consistent benefit, whereas non-standardized products yield heterogeneous and less reliable results. Cranberry products are generally safe and well tolerated, although adherence may be affected by palatability, pill burden, or uncertainty regarding product composition. Overall, cranberry may be considered a reasonable non-antibiotic prophylactic option for selected adult women, provided that counseling includes realistic discussion of expected benefits, limitations of the evidence, and the importance of using standardized preparations.</p>","PeriodicalId":23643,"journal":{"name":"Wiadomosci lekarskie","volume":"79 6","pages":"1411-1420"},"PeriodicalIF":0.0000,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Wiadomosci lekarskie","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36740/WLek/222496","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Recurrent urinary tract infections are among the most frequent bacterial infections in adult women and are associated with impaired quality of life, like repeated medical consultations, and cumulative exposure to antibiotics. In the context of increasing antimicrobial resistance, non-antibiotic preventive strategies have attracted growing attention. Cranberry products remain one of the most commonly used and most extensively studied options. The aim of this review was to summarize current evidence regarding the efficacy, safety, and practical role of cranberry products in the prevention of recurrent urinary tract infections in adult women. Contemporary guidelines, systematic reviews, meta-analyses, and randomized clinical trials indicate that cranberry products may reduce recurrence risk, particularly in women with recurrent uncomplicated cystitis. However, cranberry should not be regarded as a single uniform intervention. The clinical effect appears to depend on formulation, proanthocyanidin content, and duration of administration. Preparations providing at least 36 mg of proanthocyanidins daily seem to offer the most consistent benefit, whereas non-standardized products yield heterogeneous and less reliable results. Cranberry products are generally safe and well tolerated, although adherence may be affected by palatability, pill burden, or uncertainty regarding product composition. Overall, cranberry may be considered a reasonable non-antibiotic prophylactic option for selected adult women, provided that counseling includes realistic discussion of expected benefits, limitations of the evidence, and the importance of using standardized preparations.

蔓越莓产品预防成年女性复发性尿路感染的疗效、安全性和在非抗生素预防中的地位——文献综述。
复发性尿路感染是成年女性中最常见的细菌感染之一,并与生活质量受损有关,如反复就医和累积接触抗生素。在抗菌素耐药性日益增加的背景下,非抗生素预防策略引起了越来越多的关注。蔓越莓产品仍然是最常用和最广泛研究的选择之一。本综述的目的是总结关于蔓越莓产品在预防成年女性复发性尿路感染方面的有效性、安全性和实际作用的现有证据。当代指南、系统评价、荟萃分析和随机临床试验表明,蔓越莓产品可以降低复发风险,特别是对于复发性无并发症膀胱炎的女性。然而,蔓越莓不应被视为单一的统一干预。临床效果似乎取决于配方、原花青素含量和给药时间。每天提供至少36毫克原花青素的制剂似乎提供最一致的益处,而非标准化产品产生不均匀和不可靠的结果。蔓越莓产品通常是安全且耐受性良好的,尽管依从性可能受到适口性、药丸负担或产品成分的不确定性的影响。总的来说,对于选定的成年妇女,蔓越莓可能被认为是一种合理的非抗生素预防选择,前提是咨询包括对预期益处的现实讨论,证据的局限性,以及使用标准化制剂的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Wiadomosci lekarskie
Wiadomosci lekarskie Medicine-Medicine (all)
CiteScore
0.80
自引率
0.00%
发文量
482
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书